Tokyo: A unique compact patch created by Japanese researchers can detect the presence of Covid antibodies non-invasively in three minutes.
The University of Tokyo researchers focused on the interstitial fluid (ISF), which is found in the epidermis and dermis layers of human skin, to identify anti-Covid IgM/IgG antibodies.
The findings, published in the journal Scientific Reports, demonstrated that the novel antibody-based technique aids in the speedy and precise identification of SARS-CoV-2.
To present, the most common Covid detection procedure is swabbing the nose and mouth for samples.
However, the applicability of this technology is limited due to its long detection time (4-6 hours), expensive cost, and need for specialised equipment and medical professionals, especially in resource-poor nations.
The detection of SARS-CoV-2-specific antibodies is an alternative and supplementary approach for confirming Covid-19 infection.
In several countries, testing strips based on gold nanoparticles are now widely used for point-of-care testing. They offer sensitive and consistent findings in 10-20 minutes, but blood samples must be taken by finger prick using a lancing instrument.
This is unpleasant and raises the risk of infection or cross-contamination, and the used kit components may provide a biohazard risk.
“We investigated the possibility of sampling and evaluating the ISF to design a minimally invasive detection assay that would overcome these limitations.” Although antibody levels in the ISF are around 15-25% of those in blood, it was nevertheless possible to identify anti-SARS-CoV-2 IgM/IgG antibodies and that the ISF might operate as a direct alternative for blood sample,” stated lead author Leilei Bao from the varsity’s Institute of Industrial Science.
After proving that ISF could be used for antibody detection, the researchers devised a novel method for sampling and testing the ISF.
“First, we created biodegradable porous polylactic acid microneedles that extract ISF from human skin.”
“We then built a paper-based immunoassay biosensor to detect SARS-CoV-2-specific antibodies,” senior scientist Beomjoon Kim explained.
The lab testing revealed that by combining these two features, the tiny patch could detect antibodies on-site in 3 minutes, according to Kim.
This innovative detection technology has significant potential for quick screening of Covid-19 and many other infectious illnesses while remaining safe and acceptable to patients. According to the scientists, it has potential for usage in many nations regardless of affluence, which is a fundamental goal for global infectious disease management.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…